/Companies

Xeltis

9 known investors

Find your way into Xeltis

Sign up to see every warm intro you have to Xeltis

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Xeltis team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology. The company targets patients requiring hemodialysis vascular access or cardiovascular replacements.

Founders & leadership

ESEliane Schutte
Eliane SchutteChief Executive Officer

Investors · 9

Also in the syndicate · 3

DaVitaEuropean Innovation CouncilHorizon 3 Healthcarelead

In the news

Frequently asked questions

What does Xeltis do?
Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology. The company targets patients requiring hemodialysis vascular access or cardiovascular replacements.
Who are Xeltis's investors?
Xeltis's investors include Kurma Partners, VI Partners, Ysios Capital, Amadeus Capital Partners, EQT Life Sciences, Invest-NL.